Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.43 - $1.24 $43,000 - $124,000
-100,000 Reduced 25.3%
295,300 $182,000
Q1 2022

May 16, 2022

BUY
$0.74 - $1.79 $148,000 - $358,000
200,000 Added 102.41%
395,300 $474,000
Q4 2021

Feb 14, 2022

BUY
$1.69 - $2.46 $268,372 - $390,648
158,800 Added 435.07%
195,300 $342,000
Q3 2021

Nov 15, 2021

SELL
$2.38 - $3.77 $218,722 - $346,463
-91,900 Reduced 71.57%
36,500 $87,000
Q2 2021

Aug 16, 2021

SELL
$3.49 - $5.51 $163,946 - $258,837
-46,976 Reduced 26.79%
128,400 $470,000
Q4 2020

Feb 16, 2021

SELL
$3.08 - $7.79 $141,680 - $358,340
-46,000 Reduced 20.78%
175,376 $1.33 Million
Q3 2020

Nov 16, 2020

BUY
$2.02 - $3.08 $161,600 - $246,400
80,000 Added 56.59%
221,376 $449,000
Q2 2020

Aug 14, 2020

BUY
$2.1 - $3.42 $175,140 - $285,228
83,400 Added 143.85%
141,376 $414,000
Q1 2020

May 15, 2020

BUY
$2.31 - $4.43 $27,664 - $53,053
11,976 Added 26.03%
57,976 $139,000
Q3 2019

Nov 14, 2019

BUY
$4.33 - $11.64 $199,180 - $535,440
46,000 New
46,000 $476,000

Others Institutions Holding SLDB

About Solid Biosciences Inc.


  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $42.1M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.